Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 14 , ISSUE 1 ( January, 2010 ) > List of Articles

REVIEW ARTICLE

Top stories of 2009

Citation Information : Top stories of 2009. Indian J Crit Care Med 2010; 14 (1):3-7.

DOI: 10.4103/0972-5229.63027

License: CC BY-ND 3.0

Published Online: 00-01-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Hochreiter M, Kφhler T, Schweiger AM, Keck FS, Bein B, von Spiegel T, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomized prospective controlled trial. Crit Care. 2009;13:R83.
  2. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widemer I, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA. 2009;302:1059-66.
  3. Tsangaris I, Plachouras D, Kavatha D, Gourgoulis GM, Tsantes A, Kopterides P, et al. Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay. BMC Infect Dis 2009;9:213.
  4. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: A case-control study. J Hosp Infect 2009;73:143-50.
  5. Jamal W, Salama M, Dehrab N, Al Hashem G, Shahin M, Rotimi VO. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect 200972:234-42.
  6. Dizbay M, Tozlu DK, Cirak MY, Isik Y, Ozdemir K, Arman D. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii. J Antibiot (Tokyo)2010;63:51-3.
  7. Livermore DM, Hill RL, Thomson H, Charlett A, Turton JF, Pike R, et al. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int J Antimicrob Agents 2010;35:19-24.
  8. Towner KJ. Acinetobacter: An old friend, but a new enemy. J Hosp Infect. 2009;73:355-63.
  9. Rose L, Rogel K, Redl L, Cade Jf. Implementation of a multimodal infection control program during an Acinetobacter outbreak. Intensive Crit Care Nurs 2009;25:57-63.
  10. de Smet AM, Hopmans TE, Minderhoud AL, Blok HE, Gossink-Franssen A, et al. Decontamination of the digestive tract and oropharynx: Hospital acquired infections after discharge from the intensive care unit. Intensive Care Med 2009;35:1609-13.
  11. Derde LP, Bonten MJ. Oropharyngeal decontamination in intensive care patients: Less is not more. Crit Care. 2009;13:183.
  12. Munro CL, Grap MJ, Jones DJ, McClish DK, Sessler CN. Chlorhexidine, toothbrushing, and preventing ventilator-associated pneumonia in critically ill adults. Am J Crit Care 2009;18:428-37.
  13. Zijlstra JG, Rodgers MG, Ligtenberg JJ. Decontamination of the digestive tract in ICU patients. N Engl J Med 2009;360:2140.
  14. Panchabhai TS, Dangayach NS, Krishnan A, Kothari VM, Karnad DR. Oropharyngeal cleansing with 0.2% chlorhexidine for prevention of nosocomial pneumonia in critically ill patients: An open-label randomized trial with 0.01% potassium permanganate as control. Chest 2009;135:1150-6.
  15. Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, et al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg 2009;108:1841-7.
  16. Whittington AM, Whitlow G, Hewson D, Thomas C, Brett SJ. Bacterial contamination of stethoscopes on the intensive care unit. Anaesthesia 2009;64:620-4.
  17. Brady RR, Verran J, Damani NN, Gibb AP. Review of mobile communication devices as potential reservoirs of nosocomial pathogens. J Hosp Infect 2009;71:295-300.
  18. Byrnes MC, Schuerer DJ, Schallom ME, Sona CS, Mazuski JE, Taylor BE, et al. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices. Crit Care Med 2009t;37:2775-81.
  19. Zingg W, Imhof A, Maggiorini M, Stocker R, Keller E, Ruef C. Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections. Crit Care Med 2009;37:2167-73.
  20. Girardis M, Rinaldi L, Donno L, Marietta M, Codeluppi M, Marchegiano, et al. Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: A pilot study. Crit Care 2009;13:R143.
  21. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
  22. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, et al. Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction. Crit Care Med 2009;37:2746-52.
  23. Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med 2009;37:2071-8.
  24. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother 2009;53:3430-6.
  25. Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med 2009;37:2350-8.
  26. Vandromme MJ, McGwin G Jr, Marques MB, Kerby JD, Rue LW 3rd, Weinberg JA. Transfusion and pneumonia in the trauma intensive care unit: An examination of the temporal relationship. J Trauma 2009;67:97-101.
  27. Falagas ME, Siempos II, Rafailidis PL, Korbila LP, Loannidou E, Michalopoulos A. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: A case series. Respir Med 2009;103:707-13.
  28. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med 2010;38:954-62.
  29. Siempos II, Vardakas KZ, Kyriakopoulos CE, Ntaidou TK, Falagas ME. Predictors of mortality in adult patients with ventilator-associated pneumonia: A meta-analysis. Shock 2009 in press
  30. Morris AC, Kefala K, Simpson AJ, Wilkinson TS, Everingham K, Kerslake D, et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009;64:516-22.
  31. Wu YC, Hsu PK, Su KC, Liu LY, Tsai CC, Tsai SH, et al. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest 2009;136:118-24.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.